Cite
Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia.
MLA
Liang, Yingjian, et al. “Inhibition of Peptidylarginine Deiminase Alleviates LPS-Induced Pulmonary Dysfunction and Improves Survival in a Mouse Model of Lethal Endotoxemia.” European Journal of Pharmacology, vol. 833, Aug. 2018, pp. 432–40. EBSCOhost, https://doi.org/10.1016/j.ejphar.2018.07.005.
APA
Liang, Y., Pan, B., Alam, H. B., Deng, Q., Wang, Y., Chen, E., Liu, B., Tian, Y., Williams, A. M., Duan, X., Wang, Y., Zhang, J., & Li, Y. (2018). Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia. European Journal of Pharmacology, 833, 432–440. https://doi.org/10.1016/j.ejphar.2018.07.005
Chicago
Liang, Yingjian, Baihong Pan, Hasan B. Alam, Qiufang Deng, Yibing Wang, Eric Chen, Baoling Liu, et al. 2018. “Inhibition of Peptidylarginine Deiminase Alleviates LPS-Induced Pulmonary Dysfunction and Improves Survival in a Mouse Model of Lethal Endotoxemia.” European Journal of Pharmacology 833 (August): 432–40. doi:10.1016/j.ejphar.2018.07.005.